MINERAL OIL (HIGH VISCOSITY)
Breast Ductal Carcinoma In Situ
City of Hope Medical CentermixturePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 89/ 100
Competitive context
14 Active assets in the Breast Ductal Carcinoma In Situ cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
TAMOXIFEN National Cancer Institute (NCI) | Phase 3 | BB |
Letrozole Alliance for Clinical Trials in Oncology | Phase 3 | BB |
Arimidex Alliance for Clinical Trials in Oncology | Phase 3 | BB |
(Z)-Endoxifen Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) | Phase 2 | BB |
Metformin M.D. Anderson Cancer Center | Phase 3 | BB |
View all 22 →
Same molecule, other indications
MINERAL OIL (HIGH VISCOSITY) is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →